After second Sarepta death, Duchenne muscular dystrophy community is racked by recrimination and worry - statnews.com
- After second Sarepta death, Duchenne muscular dystrophy community is racked by recrimination and worry statnews.com
- Second patient death reported with gene therapy for muscular dystrophy AP News
- Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne Sarepta Therapeutics
- Roche Pauses Commercial and Clinical Use of Elevidys After Fatal Liver Failures WSJ
- Sarepta and Roche halt DMD gene therapy’s use after second death Yahoo Finance